Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Journal of Neuro-Oncology|February 18, 2018
Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomasDavid S Hersh, Sen Peng, Jimena G Dancy, et al.
Nucleic Acids Research|May 9, 2017
mTCTScan: a comprehensive platform for annotation and prioritization of mutations affecting drug sensitivity in cancersMulin Jun Li, Hongcheng Yao, Dandan Huang, et al.
Molecular Cancer Therapeutics|September 21, 2014
Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBCHong Zhou, Khalid A Mohamedali, Ana Maria Gonzalez-Angulo, et al.
IEEE Transactions on Automation Science and Engineering : a Publication of the IEEE Robotics and Automation Society|August 4, 2025
Weakly-Supervised Transfer Learning with Application in Precision MedicineLingchao Mao, Lujia Wang, Leland S Hu, et al.
Molecular Cancer Research : MCR|May 29, 2008
The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacityAmanda L Willis, Nhan L Tran, Julie M Chatigny, et al.
Frontiers in Oncology|April 6, 2019
Leveraging Spatial Variation in Tumor Purity for Improved Somatic Variant Calling of Archival Tumor Only SamplesRebecca F Halperin, Winnie S Liang, Sidharth Kulkarni, et al.
International Journal of Cancer|March 31, 2011
MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migrationShilpi Arora, Aarati R Ranade, Nhan L Tran, et al.
Oncotarget|January 20, 2017
Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cellsAlison Roos, Harshil D Dhruv, Ian T Mathews, et al.
Mathematical Biosciences and Engineering : MBE|October 30, 2020
Identifying the spatial and temporal dynamics of molecularly-distinct glioblastoma sub-populationsBethan Morris, Lee Curtin, Andrea Hawkins-Daarud, et al.
The Journal of Investigative Dermatology|November 30, 2012
The TWEAK receptor Fn14 is a therapeutic target in melanoma: immunotoxins targeting Fn14 receptor for malignant melanoma treatmentHong Zhou, Suhendan Ekmekcioglu, John W Marks, et al.
Pageof 12